Mumbai, 19 March 2025: USV, an Indian multinational healthcare company, has launched Xenia (Empagliflozin and its  combinations), a leading SGLT2 inhibitor, for glycemic control, heart failure and chronic kidney care in people with type 2 diabetes.  

 ......
View Details

Related News

• AIIMS forms special committee to monitor adverse drug reactions (19-03-2025)

---

• Ayush-approved medicines won't require extra safety trials for integrative research: ICMR (19-03-2025)

---

• Experts Call for Unified Action Against Counterfeiting in Supply Chains (19-03-2025)

---

• FMCG firms seek separate law for beauty products, current regulations hinder growth (18-03-2025)

---

• Mumbai: Court rejects discharge pleas of docs booked for prescribing ‘miracle drug’ of Munir Khan (18-03-2025)

---

• Raid on a factory making fake Moov and Veet creams, stock seized (18-03-2025)

---

• 616 bottles of codeine-containing cough syrup seized, 2 arrested (18-03-2025)

---

• Hair growth medicine damages eyesight! 'miracle camp' resulted in hospitalization (18-03-2025)

---

• Unlicensed Pakistani Cosmetics Seized in Pimpri-Chinchwad; legal actions set to be initiated before legislative session wraps up (18-03-2025)

---

• Pankajakasthuri Herbals faces criticism for marketing drug without proper approval (18-03-2025)

---